The China oral anticoagulants market growth continues to strengthen as the country's medical insurance and healthcare financing reforms create sustainable reimbursement pathways for anticoagulant therapies while controlling overall pharmaceutical expenditure. The National Healthcare Security Administration's dynamic adjustment mechanism for the National Reimbursement Drug List, volume-based...